Jada device clotting at y-junction reducing intrauterine suction.Patient required emergent hysterectomy [device occlusion].Case narrative: information has been received from united states food and drug administration (us fda) (medical device report (mdr) number: mw5112776 on 27-oct-2022.This spontaneous report was received from a risk manager referring to a female patient of unknown age.The patient's medical history, concurrent conditions, concomitant medications and past drug reactions/allergies were not reported.This report concerns 1 patient and 1 device.On an unknown date, the patient was inserted with vacuum-induced hemorrhage control system (jada system) by healthcare professional (lot# and expiration date were not reported) for an unknown indication.On (b)(6) 2022, the vacuum-induced hemorrhage control system (jada system) device was clotted at y-junction and reduced the intrauterine suction and the patient required emergent hysterectomy (device occlusion).It was reported that the device was not reprocessed, and the vacuum-induced hemorrhage control system (jada system) was not available for investigation.The agency considered the event of device occlusion to be serious as it required intervention.(b)(4).
|